Targeting tumor-associated immune suppression with selective protein kinase A type I (PKAI) inhibitors may enhance cancer immunotherapy

Medical Hypotheses
Muzammal HussainJiancun Zhang

Abstract

Despite the tremendous progress in last few years, the cancer immunotherapy has not yet improved disease-free because of the tumor-associated immune suppression being a major barrier. Novel trends to enhance cancer immunotherapy aims at harnessing the therapeutic manipulation of signaling pathways mediating the tumor-associated immune suppression, with the general aims of: (a) reversing the tumor immune suppression; (b) enhancing the innate and adaptive components of anti-tumor immunosurveillance, and (c) protecting immune cells from the suppressive effects of T regulatory cells (Tregs) and the tumor-derived immunoinhibitory mediators. A particular striking example in this context is the cyclic adenosine monophosphate (cAMP)-dependent protein kinase A type I (PKAI) pathway. Oncogenic cAMP/PKAI signaling has long been implicated in the initiation and progression of several human cancers. Emerging data indicate that cAMP/PKAI signaling also contributes to tumor- and Tregs-derived suppression of innate and adaptive arms of anti-tumor immunosurveillance. Therapeutically, selective PKAI inhibitors have been developed which have shown promising anti-cancer activity in pre-clinical and clinical settings. Rp-8-Br-cAMPS is a selective P...Continue Reading

References

Dec 19, 2001·Cellular Signalling·Knut Martin TorgersenKjetil Taskén
Sep 23, 2003·Experimental Cell Research·Alexander V TimoshenkoChandan Chakraborty
Jan 31, 2004·Annals of the New York Academy of Sciences·Giampaolo Tortora, Fortunato Ciardiello
Sep 24, 2005·Current Drug Targets·Bjørn Steen SkålheggSigurd Ørstavik
Oct 27, 2007·Cancer Immunology, Immunotherapy : CII·Sheraz YaqubKjetil Taskén
Mar 11, 2008·Cancer Immunology, Immunotherapy : CII·Yunyun SuElieser Gorelik
Jan 12, 2010·The Journal of Allergy and Clinical Immunology·Theresa L Whiteside
Apr 27, 2010·Expert Opinion on Biological Therapy·Theresa L Whiteside
Jun 19, 2010·The Journal of Biological Chemistry·Magis MandapathilTheresa L Whiteside
Dec 23, 2011·Clinical & Developmental Immunology·F PandolfiC Barone
Mar 23, 2012·Nature Reviews. Cancer·Matthew Vanneman, Glenn Dranoff
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
Nov 20, 2012·Nature Immunology·Drew M Pardoll
Feb 20, 2013·Journal of Cell Science·Frances R BalkwillThorsten Hagemann
Apr 27, 2013·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Muzammal HussainMuhammad Mahmood Mukhtar
Jun 4, 2013·The Journal of Clinical Investigation·Cristina Ghirelli, Thorsten Hagemann
Jun 4, 2013·The Journal of Clinical Investigation·Aurélien MarabelleRonald Levy
Jul 31, 2013·Immunity·Greg T Motz, George Coukos

❮ Previous
Next ❯

Citations

May 10, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Dickson AdahXiaoping Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.